Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study
about
Dopamine modulates von Willebrand factor secretion in endothelial cells via D2-D4 receptorsPharmacological and nonpharmacological management of delirium in critically ill patients.Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control studyAir travel and thrombosis.Population-based 5-year follow-up study in Taiwan of dementia and risk of stroke.Deep venous thrombosis and atypical antipsychotics: three cases report.Pulmonary embolism related to amisulpride treatment: a case reportAssessment of risk of venous thromboembolism and its possible prevention in psychiatric patients.Secondary effects of antipsychotics: women at greater risk than men.Risk of venous thromboembolism due to antipsychotic drug therapy.Schizophrenia: women bear a disproportionate toll of antipsychotic side effects.Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.Risk of venous thromboembolism during treatment with antipsychotic agents.Overview and assessment of risk factors for pulmonary embolism.Drug-induced thrombosis: an update.Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population.Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies.Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.Risperidone and pulmonary embolism: a harmful association? Case series and review of the literature.Delirium superimposed on dementia and mild cognitive impairment.Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD.Nonclinical aspects of venous thrombosis in pregnancy.Platelet haemostatic function in psychiatric disorders: Effects of antidepressants and antipsychotic drugs.Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophrenia.Antipsychotic drugs as a risk factor for venous thromboembolism.The Risk of Thromboembolism in Users of Antidepressants and Antipsychotics.The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation.The effects of the second generation antipsychotics and a typical neuroleptic on collagen-induced platelet aggregation in vitro.Venous thromboembolism in psychogeriatric in-patients--a study of risk assessment, incidence, and current prophylaxis prescribing.Antipsychotic drugs and risk of pulmonary embolism.Clozapine and pulmonary embolism.Fatal venous thromboembolism associated with antipsychotic therapy.Two cases of deep vein thrombosis associated with antipsychotic drug use.The changes of aggregability of blood platelets in schizophrenia.Antidepressant drug use and risk of venous thromboembolism.Pure red cell aplasia and primary antiphospholipid syndrome: a unique association.Effects of paliperidone palmitate on coagulation: an experimental study.Effects of prolactin on platelet activation and blood clotting.Effect of risperidone on serum lipids and cerebrovascular mortality among elderly dementia patients with associated behavioral disturbances.The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics.
P2860
Q24297022-3A237C5B-F2A7-4BC8-B214-8E75A1A1BE2BQ27005223-AF58956A-4188-4E65-AD1C-B1F59E190E96Q30993822-D6014F07-3959-47A3-B2FB-30452B402484Q34655409-EF47E016-1BE0-464B-8D57-6F949B0802DEQ34692331-67CBB6D9-74E5-4F17-82A7-ADC8264A5C16Q36564883-61AAAABD-DCA4-4117-BD34-BD326BE611AFQ36692244-263D74F7-CF42-492D-80E9-8F9B581EA701Q37090397-45E9C86B-D284-404E-B80B-4B9F0400B601Q37133664-3AA2502C-3A86-4AFE-807C-3156A8A0C8E1Q37537576-F2261017-4DF7-4A2F-BAE5-52A920FA3F2EQ37887304-3212E089-3C6E-4773-97E0-6088AFF24564Q38021516-C6146EA3-733F-4674-887A-0C798A6CA6F0Q38068538-FBE52C5E-4D50-49AF-9497-08D2C9872406Q38095148-A5071D22-23C4-477D-A1EE-6808B5F496A6Q38103820-0C445F11-4CFC-4977-B2C0-9FE93DF23D6CQ38115279-C2ECCFC6-EFE9-4979-A35B-31038AD50D3FQ38176847-451B99EE-4441-4B1B-8DE1-61E085D9CECBQ38214498-FF77CD46-D533-41B8-BE91-1CDF2E73EC62Q38257153-581804E1-4216-4B1D-B55E-E02019DBECAAQ38270211-84E3242F-1FA3-4158-819C-9F6CB9666267Q38418927-560635BA-9372-4205-95CF-8EE500379FFCQ38592536-ED8F5B6E-B41A-4502-AD3F-89C345662202Q38816985-CCED3967-90E1-4747-AECE-1593367C9D08Q39023872-6BDA9212-B172-4EF5-94A3-AE1B2DF6D013Q40201163-BD36D9D7-229E-4F3D-B10E-8F66ADB3F96FQ40577573-8B667DC4-0B88-43AA-995D-F96C6D3C08F6Q43135408-0F26A68D-E236-4764-A85F-F3ACBC44D17CQ43292681-2B53568D-0F15-4B34-B71F-65708AA40474Q44205661-6371D441-2FF0-4408-9F02-66E1C310790BQ44455246-3F019195-1BC3-4BB4-82B7-FC259C05DE74Q44478461-49E30DB6-C0DF-46DD-8E03-3A8B7FEC5888Q44997768-8FB38B07-5912-40AD-BD2F-BDDF95F75342Q45009940-9BEFD1A2-8B26-464B-8FE0-BD6D0041A933Q45975069-664E8EC3-C7A4-4995-BC50-6DCC786420E4Q46787520-873F26FF-1F8C-4097-BF70-88FA5D487BB7Q50582731-0CCB19B0-9E87-4784-882E-C7A071E2D4B7Q51143654-FAB5640C-FC63-472D-B659-7FE7B59AADA7Q51252028-7037D538-DFF4-41CA-B501-ECE38B0BD943Q51456912-DB4445FE-D586-40E5-ABB4-6156FD6EA3ECQ51867401-442D0C6F-BA74-4521-92EC-89B1E1F721CB
P2860
Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Antipsychotic drug use and ris ...... embolism: a case-control study
@en
Antipsychotic drug use and ris ...... embolism: a case-control study
@nl
type
label
Antipsychotic drug use and ris ...... embolism: a case-control study
@en
Antipsychotic drug use and ris ...... embolism: a case-control study
@nl
prefLabel
Antipsychotic drug use and ris ...... embolism: a case-control study
@en
Antipsychotic drug use and ris ...... embolism: a case-control study
@nl
P1433
P1476
Antipsychotic drug use and ris ...... embolism: a case-control study
@en
P2093
G L Zornberg
P304
P356
10.1016/S0140-6736(00)02784-7
P407
P50
P577
2000-10-01T00:00:00Z